Effectiveness of the cyclic administration of dienogest in a case of pathological disappearance of intestinal endometriosis

International Journal of Women's Health

Volumn 5, Issue 1, 2013, Pages 421-424

  Tamura, Ryo ^a   Tsuneki, Ikunosuke ^a   Yanase, Toru ^a  

^a NIIGATA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Atypical genital bleeding; Drug compliance; Dysmenorrhea; Endoscopy; Histology

Indexed keywords

CA 125 ANTIGEN; DIENOGEST; KEISHI BUKURYO GAN;

ABDOMINAL PAIN; ADENOMYOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; CYST; DEFECATION DISORDER; DIARRHEA; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GENITAL BLEEDING; HUMAN; HUMAN TISSUE; INTESTINAL ENDOMETRIOSIS; LONG TERM CARE; MELENA; MULTIPLE CYCLE TREATMENT; OVARY TUMOR; RECTUM; SIGMOID; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME;

EID: 84880311931     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S43567     Document Type: Article

References (10)

1. Chiou YY, Pitman MB, Hahn PF, et al. Rare benign and malignant appendiceal lesions: spectrum of computed tomography findings with pathologic correlation. J Comput Assist Tomogr. 2003;27(3):297-306.
2. Fu L, Osuga Y, Morimoto C, et al. Dienogest inhibits BrdU up-take with G0/G1 arrest in cultured endometriotic stormal cells. Fertil Steril. 2008;89(Suppl 5):1344-1347.
3. Oettel M, Carol W, Elger W, et al. A 19-norprogestin without 17 α-ethinyl group II: dienogest from a pharmacodynamic point of view. Drugs Today. 1995;312(7):517-536.
4. Sasagawa S, Shimizu Y, Nagaoka T, Tokado H, Imada K, Mizuguchi K. Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulose cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys. J Endocrinol Invest. 2008;31:636-641.
5. Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis - a randomized, double-blind, multicenter, controlled trial. Fertil Steril. 2009;91(3):675-681.
6. Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25:633-641.
7. Köhler G, Faustmann TA, Gerlinger CH, et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. Int J Gynecol Obstet. 2010;108:21-25.
8. Yanase T. [Alleviation of atypical genital bleeding by dienogest treatment: a clinical report]. Hormone Frontier in Gynecology. 2009;16(4):68-73. Japanese.
9. Kitawaki J, Kusuki I, Yamanaka K, et al. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):212-216.
10. Harada M, Osuga Y, Izumi G, et al. Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study. Gynecol Endocrinol. Sep 2011;27(9):717-720.